Skip to main content
Signal8

Krainer Adrian R.

SEC insider (Form 3/4/5 filer). CIK 0001780081. Director at Stoke Therapeutics, Inc. (STOK). 7 reported Form 4/5 transactions since Sep 2024; latest on Jun 3, 2026. Located in BEDFORD, MA.

Companies Krainer Adrian R. has filed insider reports for

  • Stoke Therapeutics, Inc. (STOK): Director
Krainer Adrian R. profile photo

Krainer Adrian R.

CIK: 0001780081

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)5 (71.4%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (28.6%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Stoke Therapeutics, Inc. logo
STOK

Stoke Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (7 total)

  • Stoke Therapeutics, Inc. logo
    STOK

    Stoke Therapeutics, Inc.

    Jun 3, 2026
    Award

    Director Stock Option (Right to Buy)

    Direct
    17.8K shares-
  • Stoke Therapeutics, Inc. logo
    STOK

    Stoke Therapeutics, Inc.

    Mar 10, 2026
    Sale
    Direct
    33.2K shares at avg. $39.74$1.3M
  • Stoke Therapeutics, Inc. logo
    STOK

    Stoke Therapeutics, Inc.

    Mar 2, 2026
    Sale
    Direct
    7.2K shares at avg. $39.66$287K
  • Stoke Therapeutics, Inc. logo
    STOK

    Stoke Therapeutics, Inc.

    Nov 24, 2025
    Sale
    Direct
    40.5K shares at avg. $29.72$1.2M
  • Stoke Therapeutics, Inc. logo
    STOK

    Stoke Therapeutics, Inc.

    Nov 14, 2025
    Sale
    Direct
    19.8K shares at avg. $26.61$527K
  • Stoke Therapeutics, Inc. logo
    STOK

    Stoke Therapeutics, Inc.

    Nov 14, 2025
    Sale
    Direct
    20.7K shares at avg. $27.34$565K
  • Stoke Therapeutics, Inc. logo
    STOK

    Stoke Therapeutics, Inc.

    Jun 3, 2025
    Award

    Director Stock Option (Right to Buy)

    Direct
    29.7K shares-

1-7 of 7